Chemicals falling under the PKDCC activators category predominantly act on cellular pathways that can indirectly modulate the activity or expression of PKDCC. For instance, chemicals that influence cyclic nucleotide concentrations, such as Rolipram, 8-Br-cAMP, and IBMX, operate by altering intracellular levels of cAMP or cGMP. As these cyclic nucleotides are potent activators of their respective kinases, namely PKA and PKG, they serve as upstream regulators of numerous cellular processes. Consequently, modulating their levels can influence various downstream targets, including PKDCC.
Furthermore, compounds like Cantharidin, which impact protein phosphatase activity, serve as checkpoints in the phosphatase-kinase dynamic equilibrium. By altering this balance, these molecules can indirectly modulate the function of various kinases, including PKDCC. Similarly, molecules like Honokiol and Oleuropein act on specific cellular targets, such as PPAR and AMPK, respectively, which serve as nodal points in intracellular signaling. Activation or modulation of such pivotal molecules can resonate throughout the cell's signaling network, influencing proteins connected through these pathways, like PKDCC. Through these mechanisms, the described chemical class ensures the comprehensive regulation of cellular signaling, with PKDCC as a participant in these intricate cascades.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a potent activator of the stress-activated protein kinase pathways. Its administration can lead to the activation of various kinases, potentially influencing the activity of PKDCC. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine is known to influence various signaling pathways, including the cAMP pathway. By increasing cAMP levels, it can activate PKA which might, in turn, affect the function of PKDCC. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4) and increases cAMP levels. This could indirectly affect PKDCC through PKA activation, as cAMP is a direct activator of PKA. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP is a cell-permeable cAMP analog. As cAMP is a direct activator of PKA, increasing its cellular concentration might influence PKDCC through subsequent signaling cascades. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific phosphodiesterase inhibitor. By increasing cellular cAMP and cGMP levels, it could impact PKDCC indirectly through various kinases modulated by these cyclic nucleotides. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
Analogous to cAMP, cGMP also activates a series of kinases. 8-Br-cGMP, a cGMP analog, might impact PKDCC by modulating kinases downstream of cGMP. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Zardaverine is a dual inhibitor of PDE3 and PDE4, leading to increased cAMP and cGMP levels in cells. This can indirectly influence PKDCC through cascades activated by these cyclic nucleotides. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin inhibits protein phosphatases 1 and 2A. By modulating phosphatase activity, it can influence various kinase pathways, potentially impacting PKDCC indirectly. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Known to activate ATP-sensitive potassium (KATP) channels. Through ion channel modulation and subsequent intracellular signaling alterations, PKDCC activity might be influenced. | ||||||
Honokiol | 35354-74-6 | sc-202653 sc-202653A | 10 mg 25 mg | $118.00 $178.00 | 4 | |
Honokiol activates PPAR, which plays roles in various signaling pathways. Its activation can modulate several kinases, potentially indirectly influencing PKDCC. | ||||||